PATENT CLAIM ANALYSIS

Application Number: 16244427
Application Type: Utility
Filing Date: 2019-01
Publication Date: 2019-05
Patent Classification: ["424", "451000"]

Abstract:
The present Disclosure is directed to methods for inhibiting or suppressing metastasis of a tumor in a mammalian subject using a cysteamine product, e.g., cysteamine or cystamine or a derivative thereof. Also described herein is a method for treating pancreatic cancer in a mammalian subject by administering a cysteamine product described herein.

Claim (Index 9):
The method of  claim 1  wherein the cysteamine, cystamine or pharmaceutically acceptable salt thereof is formulated in a tablet or capsule which is enterically coated.

Metadata:
- Claim Count in Document: 59.0
- Percentile: 99.0
- Lexical Diversity: 1.55556
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14353273', '14332829', '13277942', '15284416', '15771947']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7536209226433016
- 35 USC 102 Novelty (BERT): 0.4863695990223923
- Combined Prediction Score: 0.7268957902812108
- Mean Citation Score: 249.429072
- Max Citation Score: 254.49219
- Similarity Product: 228.6419139468938

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test